{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\nEC50 values were determined using appropriate curve fitting equations in Graphpad Prism 5.0. \nFIG. 1A shows the EC50 for six identified hits (carbetapentane, clemastine, benztropine, trifluoperazine, salmeterol, and GBR12935), all of which are FDA-approved blood-brain barrier-penetrating drugs. \nCells were treated with compounds serially diluted in DMSO (10 dilutions of 1:3 across a range of 71 \u03bcM to 4 nM)."}
{"final_json": [{"molecule_name": "carbetapentane", "protein_target_name": null, "binding_metric": "EC50", "value": null, "unit": null, "is_logarithmic": false}, {"molecule_name": "clemastine", "protein_target_name": null, "binding_metric": "EC50", "value": null, "unit": null, "is_logarithmic": false}, {"molecule_name": "benztropine", "protein_target_name": null, "binding_metric": "EC50", "value": null, "unit": null, "is_logarithmic": false}, {"molecule_name": "trifluoperazine", "protein_target_name": null, "binding_metric": "EC50", "value": null, "unit": null, "is_logarithmic": false}, {"molecule_name": "salmeterol", "protein_target_name": null, "binding_metric": "EC50", "value": null, "unit": null, "is_logarithmic": false}, {"molecule_name": "GBR12935", "protein_target_name": null, "binding_metric": "EC50", "value": null, "unit": null, "is_logarithmic": false}, {"molecule_name": null, "protein_target_name": null, "binding_metric": null, "value": "71 \u03bcM", "unit": "\u03bcM", "is_logarithmic": false}, {"molecule_name": null, "protein_target_name": null, "binding_metric": null, "value": "4 nM", "unit": "nM", "is_logarithmic": false}]}
